Evaluate Immune Response Approximately 5 to 6 Years After Receiving Different Formulations of GSK Bio Hep B Vaccine

Evaluation of the Long-term Persistence of Immunity to Hepatitis B, in Adolescents Vaccinated in Infancy With Engerix™-B Kinder

NCT01847430 ·Status: COMPLETED ·Phase: PHASE4

Long-term Persistence of Immunity Against Hepatitis B in 7-8 Years Old Children After Hepatitis B Vaccination.

NCT00519649 ·Status: COMPLETED ·Phase: PHASE4

Persistence of Immunity Against Hepatitis B in 12-13 Year Old Adolescents After Infant Hepatitis B Vaccination

NCT00984139 ·Status: COMPLETED ·Phase: PHASE4

Persistence of the Immune Response to Hepatitis B in 7-9 Years Old Children Previously Vaccinated With DTPa-HBV-IPV/Hib

NCT00356564 ·Status: COMPLETED ·Phase: PHASE4

Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,6 Month Schedule

NCT00289744 ·Status: COMPLETED ·Phase: PHASE3

Immunogenicity and Safety of GSK Biologicals' HBV-MPL Vaccine and Engerix™-B in Healthy Adults (15-40 Yrs).

NCT00697216 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate Persistence of Hepatitis B Antibodies, Immunogenicity and Safety of Engerix™-B Kinder Challenge Dose, in Adolescents Vaccinated With Four Doses of Infanrix™ Hexa During Infancy

NCT02798952 ·Status: COMPLETED ·Phase: PHASE4

This Study Aims to Determine the Long-term Persistence of Antibodies Against Hepatitis B and to Evaluate the Immunogenicity and Safety of Hepatitis B Vaccine in Adolescents Vaccinated in Infancy With Infanrix™ Hexa

NCT02052661 ·Status: COMPLETED ·Phase: PHASE4

Immunogenicity and Safety of GSK Biologicals' HBV-MPL Vaccine (2 Doses), and of Engerix™-B (3 Doses) in Healthy Adults

NCT00697853 ·Status: COMPLETED ·Phase: PHASE2

Persistence of the Immune Response to Hepatitis B in 4-6 Years Old Children Previously Vaccinated With DTPa-HBV-IPV/Hib

NCT00335881 ·Status: COMPLETED ·Phase: PHASE4

Evaluation of Immunogenicity and Reactogenicity of Various Formulations of Recombinant Hepatitis B Vaccine

NCT00697970 ·Status: COMPLETED ·Phase: PHASE3

Immunogenicity & Reactogenicity of HBV-MPL Vaccine and Engerix™-B in Healthy Adults Following 2 Different Schedules

NCT00697229 ·Status: COMPLETED ·Phase: PHASE2

Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Month Schedule

NCT00289718 ·Status: COMPLETED ·Phase: PHASE3

Immune Response of Healthy Subjects Who Received Neonatal Vaccination Course With Engerix™-B Vaccine.

NCT00774995 ·Status: COMPLETED ·Phase: PHASE4

Comparison of Monodose and Multidose Presentations of GSK Biologicals' Hepatitis B Vaccine in Terms of Immune Response

NCT00197158 ·Status: COMPLETED ·Phase: PHASE4

Comparing Immunogenicity and Safety of Different Formulations of HBV-MPL Vaccine With Engerix™-B in Adults Aged 18-40 y

NCT00698555 ·Status: COMPLETED ·Phase: PHASE2

Development of Read-outs in Healthy, Hepatitis B Virus Naive Adults Vaccinated With the Hepatitis B Surface Antigen (HBsAg) in Combination With a GlaxoSmithKline (GSK) Biologicals' Adjuvant System

NCT01777295 ·Status: COMPLETED ·Phase: PHASE2

Hepatitis B Antibody Persistence and Immune Response to Hepatitis B Vaccine Challenge in Previously Vaccinated Children

NCT01333813 ·Status: COMPLETED ·Phase: PHASE4

Evaluation of Antibody Persistence and Immune Memory Against the Hepatitis B Antigen in Previously Vaccinated Children

NCT01138098 ·Status: COMPLETED ·Phase: PHASE4

Safety and Immunogenicity of a Booster Dose of GlaxoSmithKline (GSK) Biologicals' Hepatitis B Vaccine

NCT00657657 ·Status: COMPLETED ·Phase: PHASE4

Antibody Persistence & Immune Memory in Healthy Adults Previously Vaccinated With Twinrix Adult

NCT01000324 ·Status: COMPLETED ·Phase: PHASE4

Long-term Persistence Study in Healthy Adults Previously Vaccinated With Twinrix Adult

NCT01037114 ·Status: COMPLETED ·Phase: PHASE4

Immunogenicity and Reactogenicity of MPL Adjuvanted Recombinant Hepatitis B- Vaccine and Engerix™-B in Adult Non-Responders

NCT00697931 ·Status: COMPLETED ·Phase: PHASE3

Safety and Immunogenicity of 3 Lots of GSK Biologicals' HBV-MPL Vaccine and Engerix™-B in Healthy Volunteers ≥ 15y

NCT00696917 ·Status: COMPLETED ·Phase: PHASE3

Immune Response to Hepatitis B Vaccine Challenge Dose in Subjects Who Received a Primary Neonatal Hepatitis B Vaccine.

NCT00456625 ·Status: COMPLETED ·Phase: PHASE4